<DOC>
	<DOC>NCT02931123</DOC>
	<brief_summary>This is a randomized controlled trial whose purpose is to evaluate the efficacy of therapy with lactulose and rifaximin associated with a vegetable diet in the prevention of post-TIPS hepatic encephalopathy.</brief_summary>
	<brief_title>A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<criteria>consecutive cirrhotic patients undergoing TIPS age &gt;75 years; bilirubin levels &gt;5 mg/dl; creatinine levels &gt;3 mg/dl; a serious cardiac or pulmonary dysfunction; a ChildPugh's score &gt;11 (except for the patients candidates to early TIPS); a model endstage liver disease (MELD) score &gt;18; a diagnosis of hepatic carcinoma; sepsis; spontaneous bacterial peritonitis; renal insufficiency. Present HE or previous spontaneous/recurrent HE, alcohol/psychoactive drugs intake (positive alcoholaemia and/or benzodiazepines or opioid urine metabolites) at the moment of evaluation, unrelated neurological disease including dementia (mini mental state &lt; 26).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>